Dharnidharka, Vikas R.
Webster, Angela C.
Martinez, Olivia M.
Preiksaitis, Jutta K.
Leblond, Veronique
Choquet, Sylvain
Article History
First Online: 28 January 2016
Competing interests
: S.C. reports receiving payments for consultancy, honoraria and advisory board membership from Roche. V.L. reports receiving payments for consultancy, honoraria and/or advisory board membership from Roche, Janssen, Mundipharma, Gilead and GSK. V.R.D. reports receiving payments for consultancy and honoraria from Bristol-Myers Squibb and Sanofi-Aventis, and research grant support from Novartis and Bristol-Myers Squibb. All other authors declare no competing interests.